Skip to main content

Advertisement

SpringerLink
Log in

Erectile dysfunction in the aging male

  • Published:
Current Sexual Health Reports Aims and scope Submit manuscript

Abstract

Erectile dysfunction (ED) affects a significant proportion of men, starting in middle age, with a substantial increase with each passing decade of life. This troubling condition is often not addressed in the geriatric population because of the common misconception that older men are no longer sexually active. Much of the literature regarding treatment of ED focuses on middle-aged men; however, the relative paucity of similar literature focused on the elderly belies the clinical significance of ED in this population. This article summarizes the etiology and diagnosis of ED in aging men and reviews current therapies and new developments in this common and extremely important, although often unaddressed, field of geriatric medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Feldman HA, Goldstein I, Hatzichristou DG, et al.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151:54–61.

    CAS  PubMed  Google Scholar 

  2. Blanker MH, Bosch JL, Groeneveld FP, et al.: Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology 2001, 57:763.

    Article  CAS  PubMed  Google Scholar 

  3. Shiri R, Koskimaki J, Hakkinen J, et al.: Effects of age, comorbidity and lifestyle factors on erectile function. Tampere Ageing Male Urological Study (TAMUS). Eur Urol 2004, 45:628–633.

    Article  PubMed  Google Scholar 

  4. Braun M, Wassmer G, Klotz T, et al.: Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 2000, 12:305–311.

    Article  CAS  PubMed  Google Scholar 

  5. Mulligan T, Reddy S, Gulur PV, et al.: Disorders of male sexual function. Clin Geriatr Med 2003, 19:473–481.

    Article  PubMed  Google Scholar 

  6. Morgentaler A: Male impotence. Lancet 1999, 354:1713–1718.

    Article  CAS  PubMed  Google Scholar 

  7. Nehra A: Treatment of endocrinologic male sexual dysfunction. Mayo Clin Proc 2000, 75(Suppl):S40.

    CAS  PubMed  Google Scholar 

  8. Davidson JM, Kwan M, Greenleaf WJ: Hormonal replacement and sexuality in men. Clin Endocrinol Metab 1982, 11:599–623.

    Article  CAS  PubMed  Google Scholar 

  9. Baba K, Yajima M, Carrier S, et al.: Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibers and the erectile response in rat penis. Br J Urol 2000, 85(7):953–958.

    CAS  Google Scholar 

  10. Araujo AB, Durante R, Feldman HA, et al.: The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998, 60:458–465.

    CAS  PubMed  Google Scholar 

  11. Rosen RC, Cappelleri JC, Smith MD, et al.: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11(6):319–326.

    Article  CAS  PubMed  Google Scholar 

  12. Wein AJ, Van Arsdalen KA: Drug-induced male sexual dysfunction. Urol Clin North Am 1988, 15:23–31.

    CAS  PubMed  Google Scholar 

  13. Yesavage JA, Brink TL, Rose TL, et al.: Development and validation of a geriatric depression rating scale: a preliminary report. J Psychiatr Res 1983, 17:37–49.

    Article  CAS  Google Scholar 

  14. Morgentaler A: A 66-year-old man with sexual dysfunction. JAMA 2004, 291(24):2994–3003.

    Article  CAS  PubMed  Google Scholar 

  15. Wagner G, Montorsi F, Auerbach S, et al.: Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis. J Gerontol A Biol Sci Med Sci 2001, 56:M113-M119. This study analyzed two subgroups of elderly patients with ED, those with ED of broad-spectrum etiology and those with ED and diabetes. Results showed that sildenafil significantly improved erectile function in both groups.

    CAS  PubMed  Google Scholar 

  16. Fujisawa M, Sawada K: Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction. Arch Androl 2004, 50:255–260.

    Article  CAS  PubMed  Google Scholar 

  17. Porst H, Young JM, Schmidt AC, et al.: Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups. Urology 2003, 62(3):519–523. This study evaluated vardenafil in three different strengths versus placebo in 580 men. In all age groups, including the older-than-65-year group (n=64), vardenafil improved erectile function measured by IIEF scores.

    Article  PubMed  Google Scholar 

  18. Porst H, Padma-Nathan H, Giuliano F, et al.: Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology 2003, 62:121–125.

    Article  PubMed  Google Scholar 

  19. Brock GB, McMahon CG, Chen KK, et al.: Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002, 168:1332–1336.

    Article  CAS  PubMed  Google Scholar 

  20. Linet OI, Ogrinc FG, for the Alprostadil Study Group: Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med 1996, 334(14):873–877.

    Article  CAS  PubMed  Google Scholar 

  21. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al.: Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 1997, 336:1–7.

    Article  CAS  PubMed  Google Scholar 

  22. Shabsigh R, Padma-Natahan H, Gittleman M: Intracavernous alprostadil alfadex is more efficacious, better tolerated and preferred over intraurethral alprostadil plus optional ACTIS: a comparative, randomized crossover, multi-center study. Urology 2000, 55:109–113.

    Article  CAS  PubMed  Google Scholar 

  23. Nadig PW, Ware JC, Blumoff R: Noninvasive device to produce and maintain an erection-like state. Urology 1986, 27:126–131.

    Article  CAS  PubMed  Google Scholar 

  24. Chen J, Mabjeesh NJ, Greenstein A: Sildenafil versus the vacuum erection device: patient preference. J Urol 2001, 166:1779–1781.

    Article  CAS  PubMed  Google Scholar 

  25. Rajpurkar A, Dhabuwala CB: Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile function in urology practice. J Urol 2003, 170:159–163.

    Article  CAS  PubMed  Google Scholar 

  26. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H: Randomized study of testosterone gel as adjunctive therapy to Sildenafil in hypogonadal men with erectile dysfunction who do not respond to Sildenafil alone. J Urol 2004, 172:658–663.

    Article  CAS  PubMed  Google Scholar 

  27. Allard J, Giuliano F: Central nervous system agents in the treatment of erectile dysfunction: how do they work? Curr Urol Rep 2001, 2:488–494.

    Article  CAS  PubMed  Google Scholar 

  28. Martinez R, Puigvert A, Pomerol JM, Rodriguez-Villalba R: Clinical experience with apomorphine hydrochloride: the first 107 patients. J Urol 2003, 170:2352–2355.

    Article  CAS  PubMed  Google Scholar 

  29. Pavone C, Curto F, Anello G, et al.: Prospective randomized crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. J Urol 2004, 172(6 pt 1):2347–2349.

    Article  CAS  PubMed  Google Scholar 

  30. Eardley I, Wright P, MacDonagh R, et al.: An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction. BJU Int 2004, 93(9):1271–1275.

    Article  CAS  PubMed  Google Scholar 

  31. Costabile R, Spevak M: Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial. J Urol 1999, 161:1819–1822.

    Article  CAS  PubMed  Google Scholar 

  32. Fink HA, MacDonald R, Rutks IR, Wilt TJ: Trazodone for erectile dysfunction: a systematic review and meta-analysis. BJU Int 2003, 92:441–446. This recent meta-analysis examined six trials in which the effect of trazodone on ED was assessed. Trazodone in three of six trials showed clinically significant improvement in ED. Results indicated that the drug, in higher doses, may be more helpful in men with psychogenic ED.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Geriatrics, St. Luke’s/Roosevelt Hospital, 1111 Amsterdam Avenue, 10025, New York, NY, USA

    Lizette J. Smith MD

Authors
  1. Lizette J. Smith MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, L.J. Erectile dysfunction in the aging male. Current Sexual Health Reports 2, 13–16 (2005). https://doi.org/10.1007/s11930-005-0016-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11930-005-0016-9

Keywords

Search

Navigation